Results 11 to 20 of about 2,610,836 (314)

Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast [PDF]

Clinics, 2013
OBJECTIVE: To determine the frequency of the immunohistochemical profiles of a series of high-grade ductal carcinoma in situ of the breast. METHODS: One hundred and twenty-one cases of high-grade ductal carcinoma in situ, pure or associated with ...
Balabram, Débora, da Silva Souza, Átila, Gobbi, Helenice, Perez, Amanda Arantes, Rocha, Rafael Malagoli   +4 more
core   +5 more sources

Potential biomarkers of ductal carcinoma in situ progression

BMC Cancer, 2019
Ductal carcinoma in situ is a non-obligate precursor of invasive breast carcinoma and presents a potential risk of over or undertreatment. Finding molecular biomarkers of disease progression could allow for more adequate patient treatment.
R. S. Dettogni, E. Stur, A. C. Laus, R. A. da Costa Vieira, M. Marques, I. Santana, J. Pulido, Laura Fregonassi Ribeiro, Narelle de Jesus Parmanhani, L. P. Agostini, R. S. dos Reis, Eldamária de Vargas Wolfgramm dos Santos, L. N. R. Alves, F. M. Garcia, Jéssica Aflávio Santos, Diego do Prado Ventorim, R. Reis, I. Louro   +17 more
semanticscholar   +2 more sources

Context-aware stacked convolutional neural networks for classification of breast carcinomas in whole-slide histopathology images [PDF]

arXiv, 2017
Automated classification of histopathological whole-slide images (WSI) of breast tissue requires analysis at very high resolutions with a large contextual area. In this paper, we present context-aware stacked convolutional neural networks (CNN) for classification of breast WSIs into normal/benign, ductal carcinoma in situ (DCIS), and invasive ductal ...
Balkenhol, Maschenka, Bejnordi, Babak Ehteshami, Bult, Peter, Hermsen, Meyke, Karssemeijer, Nico, Litjens, Geert, van der Laak, Jeroen, van Ginneken, Bram, Zuidhof, Guido   +8 more
arxiv   +3 more sources

Association of clinico-pathological and immunohistochemical prognostic parameters with presence of ductal carcinoma in-situ in an invasive ductal carcinoma of breast

Journal of Pathology of Nepal, 2023
Background: The clinical outcome of breast carcinoma varies in each individual due to its molecular heterogeneity. There is a rising interest in whether the associated ductal carcinoma in-situ in invasive ductal carcinoma of breast affects the prognosis ...
Dhivya Balaiya, Anitha Chellam Annadurai, Jayakarthiga Subbiah Rajendran   +2 more
doaj   +1 more source

Immunohistochemical Expression of p63 in Benign and Malignant Breast Lesions [PDF]

Journal of Clinical and Diagnostic Research, 2021
Introduction: Breast carcinoma demands attention as it causes high morbidity and mortality. It is important to recognise benign lesions to distinguish them from in situ and invasive breast cancer and to assess a patient’s risk of developing breast ...
Abhishek Saini, Swaran Kaur Saluja, MK Garg, Deepti Agarwal, Amrita Kulhri, Anjali Sindhu, Smriti Singh   +6 more
doaj   +1 more source

An Unusual Presentation of Extensive Ductal Carcinoma in Situ Accompanying Invasive Ductal Carcinoma on MRI: A Case Report

대한영상의학회지, 2022
The incidence of ductal carcinoma in situ has increased with the rise in screening mammography; currently, ductal carcinoma in situ constitutes 20%–25% of all breast cancers, and up to half of them may become invasive.
Yeon Jung Kim, Hyun Kyung Jung, Woogyeong Kim
doaj   +1 more source

Lipid metabolism in pancreatic cancer: emerging roles and potential targets

Cancer Communications, Volume 42, Issue 12, Page 1234-1256, December 2022., 2022
Abstract Pancreatic cancer is one of the most serious health issues in developed and developing countries, with a 5‐year overall survival rate currently <9%. Patients typically present with advanced disease due to vague symptoms or lack of screening for early cancer detection.
Xinpeng Yin, Ruiyuan Xu, Jianlu Song, Rexiati Ruze, Yuan Chen, Chengcheng Wang, Qiang Xu   +6 more
wiley   +1 more source

Profile of Digital Mammography Findings in Patients with Histopathologically Proven Ductal Carcinoma in Situ (DCIS)

Galician Medical Journal, 2020
Breast carcinoma is a heterogeneous group of tumors with a wide spectrum of clinical presentations, lesion characterization and diagnostic evaluation.
Ankit Prabhakar, Dawood Iqbal Wani, Shivani Sharma, Sajjad Ahmad Dar, Shaafiya Ashraf   +4 more
doaj   +1 more source

Breast Ductal Carcinoma In Situ [PDF]

International Journal of Surgical Oncology, 2012
Ductal carcinoma in situ (DCIS) of the breast is becoming one of the most important diseases diagnosed in preventive medicine screening. The current age-adjusted incidence rate of DCIS is 32.5 per 100,000 women. For women 50–64 years of age, the incidence is approximately 88 per 100,000. Currently, for every 4 diagnoses of invasive breast cancer, there
V. Sacchini, L. Fortunato, H. S. Cody Iii, K. J. Van Zee, B. Cutuli, B. Bonanni   +5 more
openaire   +3 more sources

Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management

Cancer Communications, Volume 42, Issue 12, Page 1257-1287, December 2022., 2022
Abstract Clustered regularly interspaced short palindromic repeats‐associated protein (CRISPR/Cas9), an adaptive microbial immune system, has been exploited as a robust, accurate, efficient and programmable method for genome targeting and editing. This innovative and revolutionary technique can play a significant role in animal modeling, in vivo genome
Khaled S. Allemailem, Mohammed A Alsahli, Ahmad Almatroudi, Faris Alrumaihi, Fahd Khaleefah Alkhaleefah, Arshad Husain Rahmani, Amjad Ali Khan   +6 more
wiley   +1 more source